A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
BACKGROUND:Neoadjuvant chemotherapy (NAC) allows earlier treatment of rectal cancer micro-metastases but is not standard of care. There are currently no biomarkers predicting long-term progression-free survival (PFS) benefit from NAC. PATIENTS AND METHODS:In this single arm phase II trial, patients...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Otros Autores: | |
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
Springer Nature
2019
|